Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 2.4 Articles of Association Adopted As of June 20, 2006
- 2.5 Terms of Reference of Audit Committee
- 4.52 Anthony Fabrizi Letter of Resignation
- 4.53 Rules of Executive Share Option Scheme 2005
- 4.54 Contract for Sale
- 4.55 Joint Venture Agreement
- 4.56 Licence Agreement Between Crescent Pharma and Dexo Biogenerics
- 4.57 Licence Agreement Between Bioprogress and Dexo Biogenerics
- 4.58 Loan Agreement Between Dexo Biopharm and Dexo Biogenerics
- 4.59 Services Agreement Between Bioprogress and Dexo Biogenerics
- 4.60 Services Agreement Between Crescent Pharma and Dexo Biogenerics
- 4.61 Share Purchase Agreement
- 4.62 Orderly Market Agreement
- 4.63 Lock-up Agreement
- 4.64 Tony Knight Second Ned Letter of Appointment
- 4.65 Alan Clarke Second Ned Letter of Appointment
- 4.66 Peter Ibbetson Second Ned Letter of Appointment
- 4.67 Research Collaboration and Option Agreement
- 4.68 Peter Keen Service Agreement
- 4.69 Licence to Assign
- 4.70 Transfer of Title
- 4.71 Lease for Science Park Property
- 8.1 List of the Company's Subsidiaries
- 10.1 Consent of Grant Thornton
- 11.1 Code of Conduct
- 12.1 Certification of Chief Executive Officer
- 13.1 Section 1350 Certification of Chief Executive Officer
BPRS similar filings
Filing view
External links